If you’re suffering from chronic pain, your doctor may have already recommended a treatment regimen that includes opiates or other strong analgesics medications. Currently, opioids are often the primary treatment option for moderate-to-severe chronic pain, and they have significant side effects, including addiction, lethargy, confusion, constipation and respiratory depression. among others. In other cases, your doctor may recommend a more invasive or permanent treatment option, such as a permanently implanted neurostimulator, radiofrequency ablation (RF), or surgery.
All treatments, including those mentioned above have associated risks that may include those related to surgery, anesthesia, infection related to a permanent implant, and unintended and potentially irreversible tissue damage, among others.
THE SPRINT PNS SYSTEM — A NEW WAY TO TREAT CHRONIC PAIN.
Unlike pain medications, invasive treatments, and permanent implants, the SPRINT PNS System offers a drug-free, minimally invasive alternative to treating chronic pain. Because the system is minimally invasive and completely reversible, your physician may use it quite a bit earlier in your treatment process potentially eliminating the need for opiates or other more costly or invasive pain management alternatives.
Placed by your physician during an outpatient procedure and without the need for general anesthesia, the SPRINT PNS System uses a small, wearable stimulator connected to a thread-like wire lead to deliver tiny electrical pulses to stimulate nerves in a manner that is intended to provide targeted pain relief. The lead is intended to remain implanted for up to 60 days, after which it is withdrawn by your physician.
A SOLUTION WITH IMPRESSIVE RESULTS.
Signiﬁcant Pain Relief
Experienced clinically significant improvements in their pain or in the extent to which pain interfered with their life to include work, mood, general activities, sleep, and enjoyment of life, for example.
Subjects continued to experience Clinically Significant Pain Relief at 12 months post-treatment
While SPRINT is indicated for use for up to 60 days, subjects receiving SPRINT have experienced lasting clinical
benefits after the short-term therapy3.